News of My Company from Halter Financial Group

Tiens Biotech Group (USA) Chairman Jinyuan Li Named One of the Top Ten Men of the Year in China

Tiens Biotech Group (USA), Inc. (OTC Bulletin Board: TBGU - News), which operates primarily through its subsidiary Tianjin Tianshi Biological Development Co., Ltd ("Biological"), today announced that Jinyuan Li, Chairman, President and CEO of the company, has been named One of the Top Ten Men of the Year for 2004 in China. He received the award in recognition for his significant achievements in corporate management and in the field of economics.

The award was presented jointly by China Domestic and Foreign Celebrity Culture Seminar, China Contemporary Celebrity Academy, and China Fortune Forum Journal. This ceremony was held in the Great Hall of the People in Beijing, China on January 8, 2005. The forum was to honor corporate executives whose insights have benefited Chinese society and helped promote the development of China as a worldwide business leader.
Jinyuan Li, Chairman, President and CEO of Tiens Biotech Group (USA), Inc., said, "I am greatly honored to have been selected to receive this most prestigious award. I am proud of being part of the recognition China is receiving for its expansion in a broad spectrum of key industries and the growing acceptance of our fine products and services throughout the world."

About Tiens Biotech Group (USA), Inc.
Tiens Biotech Group (USA), Inc. ("the Company" or "Tiens") conducts its main business through its subsidiary Tianjin Tianshi Biological Development Co., Ltd ("Biological"), which has its headquarters in Beijing, China, and production plants in Tianjin, China's third largest city. In September 2003, Tiens completed a reverse merger with Strategika, Inc. and received approval for the company's formal name and symbol changes in February 2004. In China, Tiens sells its products through 22 branches, representative offices and chain stores and 12 domestic affiliate companies of its affiliate company, Tianjin Tianshi Biological Engineering Co., Ltd. Internationally, the Company markets its products to approximately 90 countries on six continents.

Tiens Biotech Group (USA), Inc. is primarily engaged in the research, development, manufacturing and marketing of healthcare products including herbal products, vitamin and mineral supplements and personal care. Since its establishment, the company has developed 7 major product series and produced 45 types of healthcare products. Among these are 27 healthcare food products, 23 of which have obtained the "Health Food Certificates" issued by the PRC Ministry of Health. The 7 major product series are: High-Calcium Series, Immune System Adjustment Series, Nutrient Supplements Series, Cholesterol Adjustment Series, High-Fiber Series, Heart and Brain Improvement Series and Personal Care Series. Under the High-Calcium series, Tiens has conducted extensive research and developed Tianshi Super Calcium with Metabolic Factors and Tianshi Super Calcium Powder for Children, which have been awarded patents from the State Intellectual Properties Office in China with respective patent numbers of ZL97115067.2 and ZL97115068.0.

Source: http://www.halter.com.cn/case/info.asp?id=9

What is Halter Financial Group?
Founded in 1995, Halter Financial Group (HFG) is a leading U.S. based consulting firm specializing in taking companies public through the reverse merger and alternative public offering process “APO” (a contemporaneous reverse merger transaction with a private placement equity capital raise).